LYCOS RETRIEVER 
The Millennium: U.S
built 186 days ago
Millennium is committed to pursuing oncology as a core franchise area, dedicating significant resources and capabilities in the areas of technology, scientific expertise, clinical development, and strategic business development. To this end, Millennium is focused on leveraging its expertise in kinases, the proteasome pathway, and targeting monoclonal antibodies, and has already produced a deep pipeline that ranges from multiple novel targets to a commercialized therapeutic product. Among the Company's most advanced clinical compounds in addition to bortezomib (VELCADE) are MLN518, MLN591RL, MLN2704 and MLN576 (XR11576). Alemtuzumab (U.S. brand name Campath(R), EU brand name MabCampath(R)), a therapeutic developed from a former joint venture of Millennium and ILEX Oncology, Inc., is commercially available in the United States and a number of European countries.
Source:
Greenwich 2000: Millennium Timeline - Greenwich, England was settled in the year 49 A.D. These timelines cover 49-2000. Have your students determine where U.S. history fits into the Greenwich timeline. Don't forget to include the founding of your town and your school.
Source:
In June 2003, Millennium entered into an agreement with Ortho Biotech Products, L.P. to collaborate on the commercialization and continued clinical development of VELCADE. Under the terms of the agreement, Ortho Biotech and its affiliate, Janssen-Cilag, commercialize VELCADE outside of the U.S. and Millennium receives royalties on sales outside of the U.S. In addition, Millennium may receive payments for achieving clinical, development and regulatory approvals and sales milestones outside of the U.S.
Source:
MORE ABOUT
U.S